Literature DB >> 16934201

HIV coinfection with hepatitis C and hepatitis B.

Jenny O Smith1, Richard K Sterling.   

Abstract

HIV, hepatitis C virus, and hepatitis B virus are global health concerns. Due to shared routes of transmission, coinfection is common. The incidence of liver-related mortality in coinfected patients has risen significantly since the inception of highly active antiretroviral therapy, a treatment that has helped decreased mortality rates from AIDS and opportunistic infections. This trend has led to increased research into the evaluation and management of the coinfected patient. This article details the principles of successful management of this challenging patient population.

Entities:  

Year:  2006        PMID: 16934201     DOI: 10.1007/s11908-006-0053-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  53 in total

Review 1.  Care of patients with hepatitis C and HIV co-infection.

Authors:  Vincent Soriano; Massimo Puoti; Mark Sulkowski; Stefan Mauss; Patrice Cacoub; Antonietta Cargnel; Douglas Dieterich; Angelos Hatzakis; Jurgen Rockstroh
Journal:  AIDS       Date:  2004-01-02       Impact factor: 4.177

Review 2.  Hepatitis B or hepatitis C and human immunodeficiency virus infection.

Authors:  Robert Thimme; Hans Christian Spangenberg; Hubert E Blum
Journal:  J Hepatol       Date:  2005-01-28       Impact factor: 25.083

3.  An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.

Authors:  M Nelson; S Portsmouth; J Stebbing; M Atkins; A Barr; G Matthews; D Pillay; M Fisher; M Bower; B Gazzard
Journal:  AIDS       Date:  2003-01-03       Impact factor: 4.177

4.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

5.  Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Authors:  Thomas B Kelleher; Shruti H Mehta; Ramakrishnan Bhaskar; Mark Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Journal:  J Hepatol       Date:  2005-04-25       Impact factor: 25.083

6.  Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.

Authors:  Marina Núñez; Massimo Puoti; Nuria Camino; Vincent Soriano
Journal:  Clin Infect Dis       Date:  2003-10-29       Impact factor: 9.079

7.  Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Authors:  Jürgen K Rockstroh; Amanda Mocroft; Vincent Soriano; Cristina Tural; Marcello H Losso; Andrzej Horban; Ole Kirk; Andrew Phillips; Bruno Ledergerber; Jens Lundgren
Journal:  J Infect Dis       Date:  2005-08-11       Impact factor: 5.226

8.  Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.

Authors:  Yves Benhamou; Herve Fleury; Pascale Trimoulet; Isabelle Pellegrin; Renaud Urbinelli; Christine Katlama; Willy Rozenbaum; Gwenael Le Teuff; Aldo Trylesinski; Christophe Piketty
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

9.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

10.  Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.

Authors:  Katie B Anderson; Jodie L Guest; David Rimland
Journal:  Clin Infect Dis       Date:  2004-10-25       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.